5 August 2020
Researchers from the MRC-Human Immunology Unit, supported by the NIHR Oxford Biomedical Research Centre, have used an ‘atlas’ of immune cells in the human colon to find evidence of the role of CD8 T cells in inflammatory bowel disease. The findings could pave the way for more targeted treatments for this chronic disorder.
22 July 2020
Researchers at the MRC Weatherall Institute of Molecular Medicine have recently discovered why a class of cancer drugs is beneficial only in a subset of patients. The results could pave the way for the future development of these drugs, known as PNP-inhibitors, as personalised medicines.
6 July 2020
A major UK research study into the long-term health impacts of COVID-19 on hospitalised patients has been launched.
9 June 2020
The study builds on a successful collaboration and will compare T cell and antibody responses to uncover the role of ‘background’ immunity to virus strains already in circulation, including infections with similar coronaviruses.
10 March 2020
Professor of Immunology Tao Dong from the MRC Human Immunology Unit (MRC HIU) appeared on BBC Radio 4’s The World This Weekend to discuss her group’s coronavirus research.
20 February 2020
Congratulations to Dr Erdinc Sezgin, who will be part of the prestigious SciLifeLab Fellowship programme and the Karolinska Institutet.
3 February 2020
Many congratulations to Prof Anne Goriely and Prof Alison Simmons, who have both been awarded Wellcome Trust Investigator Awards.
7 November 2019
Many congratulations to Prof Ahmed Ahmed and Prof Enzo Cerundolo, winners of the Ovarian Cancer Action International Grand Challenge Award.
23 October 2019
A therapy that targets the immune system showed promise for treating atopic dermatitis – the most common form of eczema – in a small proof-of-concept trial, led by scientists from the MRC HIU.
11 October 2019
New Oxford start-up is established to develop novel therapeutics based on the expertise of the Davis and Cornall groups at MRC HIU.
10 October 2019
New research by the Drakesmith group and collaborators shows that BMP inhibitors are able to reverse the main untreatable symptom of the disease.